Skip to main
  1. Stocks
  2. NeuroSense Therapeutics Ltd
  3. P/E Ratio
NRSN

NRSN P/E Ratio

P/E Ratio as of Oct 28, 2026: -0.20

Average-0.2878
Median-0.3000
Minimum-0.4400
Maximum-0.2000
-0.20
0.39 (66.10%)past month
The P/E ratio for NRSN is -0.20 as of Oct 28, 2026. This represents a increase of 150.00% compared to its 12-month average P/E ratio of -0.08. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

NeuroSense Therapeutics Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

NeuroSense Therapeutics Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing NeuroSense Therapeutics Ltd to industry peers.

NRSN P/E Ratio Insights

See NeuroSense Therapeutics Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in NRSN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NRSN P/E Ratio Historic Data

DateStock priceP/E ratio
Oct 1, 2026$4.05-0.35
Sep 15, 2026$7.03-0.60

NRSN End of Year P/E Ratio

DateP/E ratioChange
2026-0.20—

FAQs About NeuroSense Therapeutics Ltd (NRSN) P/E ratio

The latest P/E ratio of NRSN is -0.20, as of Oct 28, 2026. This is calculated based on its current stock price and earnings per share (EPS).

NeuroSense Therapeutics Ltd’s last 12-month average P/E ratio is -0.08, compared to its current P/E ratio of -0.20. This reflects a increase of 150.00%.

NeuroSense Therapeutics Ltd’s current P/E ratio of -0.20 is higher than its last 12-month average P/E of -0.08. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

NeuroSense Therapeutics Ltd’s average P/E ratio over the last 3 years is -0.03. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

NeuroSense Therapeutics Ltd’s average P/E ratio over the last 5 years is -0.02. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

NeuroSense Therapeutics Ltd (NRSN)


NRSN P/E Ratio Insights

See NeuroSense Therapeutics Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in NRSN

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover NRSN stock data and trends